checkAd
    Startseite > Aktien > Precision BioSciences > Nachrichten
    Precision BioSciences Aktie
    10,500
     
    EUR
    +7,69 %
    +0,750 EUR
    Letzter Kurs 08.05.24 Tradegate
    10,400
     
    EUR
    291 STK
    Geldkurs 08:00:13
    10,600
     
    EUR
    282 STK
    Briefkurs 08:00:13
    ISIN: US74019P2074 · WKN: A400AS · SYM: PBS0 · USA

    Neueste Nachrichten

    Precision BioSciences Announces Common Stock Purchase by Members of Management for $300,000 in a Private Placement
    08.05.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences to Report First Quarter Results on May 13, 2024
    07.05.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency
    07.05.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences Announces Late-Breaking Poster Presentation at the European Association for Study of the Liver (EASL) Congress 2024
    01.05.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
    16.04.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
    27.03.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024
    20.03.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy
    19.03.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency
    06.03.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants
    01.03.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences Announces Proposed Public Offering of Common Stock and Warrants
    29.02.24 · Business Wire (engl.) · Precision BioSciences
    Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences
    20.02.24 · Business Wire (engl.) · Precision BioSciences